Irreversible electroporation of the pancreas in swine: a pilot study

被引:98
作者
Charpentier, Kevin P. [1 ]
Wolf, Farrah [2 ]
Noble, Lelia [3 ]
Winn, Brody [3 ]
Resnick, Murray [3 ]
Dupuy, Damian E. [2 ]
机构
[1] Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA
[2] Brown Univ, Rhode Isl Hosp, Dept Radiol, Providence, RI 02903 USA
[3] Brown Univ, Rhode Isl Hosp, Dept Pathol, Providence, RI 02903 USA
关键词
pancreas; ablation; irreversible; electroporation; NECK-CANCER; THERAPY; HEAD; ABLATION;
D O I
10.1111/j.1477-2574.2010.00174.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Irreversible electroporation (IRE) is a novel, non-thermal method of tissue ablation using short pulses of high-voltage DC current to ablate tissue. Methods: Irreversible electroporation of the pancreas was performed in four domestic female swine using two monopolar probes spaced 9-15 mm apart. Ninety pulses of 1500 V/cm were delivered for each ablation. Results: All animals survived for their designated times of 2 h (n = 1), 2 days (n = 1) and 14 days (n = 2), respectively. No procedure-related complications occurred. Three animals in which probes had been spaced at intervals of 10 +/- 1 mm showed evidence of irreversible ablation, with ablation height ranging from <10 mm to 21 mm and ablation width ranging from <10 mm to 16 mm by gross appearance and triphenyltetrazolium chloride (TTC) staining. The only animal in which probes had been spaced at intervals of 15 mm did not show evidence of irreversible ablation at 2 weeks. This may be secondary to the wider probe spacing and relatively low voltage, which results in a mostly reversible form of electroporation without cell death. Conclusions: Irreversible electroporation appears to be a safe method for pancreas tissue ablation. Staining with TTC can predict the zone of IRE ablation within 2 h of treatment.
引用
收藏
页码:348 / 351
页数:4
相关论文
共 10 条
  • [1] Electroporation therapy for head and neck cancer including carotid artery involvement
    Allegretti, JP
    Panje, WR
    [J]. LARYNGOSCOPE, 2001, 111 (01) : 52 - 56
  • [2] ALSAKERE B, 2007, PLOS ONE, V11, P1
  • [3] The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck
    Bloom, DC
    Goldfarb, PM
    [J]. EJSO, 2005, 31 (09): : 1029 - 1035
  • [4] CHARPENTIER KP, 2010, ANN M SOC SURG ONC S
  • [5] Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation
    Lee, Edward W.
    Loh, Christopher T.
    Kee, Stephen T.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (04) : 287 - 293
  • [6] Cancer cells ablation with irreversible electroporation
    Miller, L
    Leor, J
    Rubinsky, B
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (06) : 699 - 705
  • [7] Mechanisms of electrochemotherapy
    Mir, LM
    Orlowski, S
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (01) : 107 - 118
  • [8] Electroporation therapy of head and neck cancer
    Panje, WR
    Hier, MP
    Garman, GR
    Harrell, E
    Goldman, A
    Bloch, I
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1998, 107 (09) : 779 - 785
  • [9] Enhancing the Effectiveness of Drug-based Cancer Therapy by Electroporation (Electropermeabilization)
    Rabussay, Dietmar P.
    Nanda, Gurvinder S.
    Goldfarb, Paul M.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (01) : 71 - 82
  • [10] Irreversible electroporation: A new ablation modality - Clinical implications
    Rubinsky, Boris
    Onik, Gary
    Mikus, Paul
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (01) : 37 - 48